The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prost… (NCT07529418) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study
800 participantsStarted 2026-05-05
Plain-language summary
The BALANCE study is a prospective Patient Reported Outcomes Measures (PROMs) study developed to look at the quality of life (QoL) of patients diagnosed with prostate cancer (PCa) in communities underrepresented in research, especially Black men of African, and Caribbean ancestry as well as men of Mixed ethnicity. This study will also investigate various PCa treatment types and their mental health impact on patients. There is a lack of research on PROMs in diverse populations. Collecting PROMs specifically from Black men and individuals with prostates who are receiving/have received treatment for PCa is essential for understanding their unique post-treatment experiences. The insights are vital to addressing documented disparities, tailoring supportive care and ultimately providing equitable health outcomes.
Participants in this study will be asked to complete a questionnaire (either electronically or hardcopy) to share their insights following their PCa diagnosis.
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
* Age ≥ 18 years;
* Be of either:
* Black African ancestry; OR
* Black African-Caribbean ancestry; OR
* Mixed Black ancestry.
* Diagnosed with PCa;
* Assigned male at birth;
* Participants with access to digital devices (smartphones, tablets, computers) or able to complete hardcopy versions of the survey;
* Participants willing to participate and provide informed consent.
Exclusion Criteria:
A potential subject who meets any of the following criteria will be excluded from participation in this study:
* Participants having no diagnosis of PCa;
* Participants unable to provide consent;
* Participants assigned female at birth.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The impact of prostate cancer on quality of life
Timeframe: 18 months
2
The physical impact of treatments on quality of life
Timeframe: 18 months
3
The impact of treatments in mental health outcomes
Timeframe: 18 months
4
The functional impact of treatments on quality of life
Timeframe: 18 months
5
Variation in health and wellbeing outcomes by treatment type and sociodemographic characteristics.
Timeframe: 18 months
Trial details
NCT IDNCT07529418
SponsorInstitute of Cancer Research, United Kingdom